NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported second-quarter profit of $18 million.

On a per-share basis, the New York-based company said it had net income of 3 cents. Earnings, adjusted for non-recurring costs, came to $1.32 per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.27 per share.

The company posted revenue of $674 million in the period. Its adjusted revenue was $773 million.

Royalty Pharma expects full-year revenue in the range of $3.4 billion to $3.5 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX